rs114838275

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001042413.2(GLIS3):​c.1430C>T​(p.Ala477Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000356 in 1,591,170 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0019 ( 2 hom., cov: 31)
Exomes 𝑓: 0.00019 ( 1 hom. )

Consequence

GLIS3
NM_001042413.2 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 2.05

Publications

0 publications found
Variant links:
Genes affected
GLIS3 (HGNC:28510): (GLIS family zinc finger 3) This gene is a member of the GLI-similar zinc finger protein family and encodes a nuclear protein with five C2H2-type zinc finger domains. This protein functions as both a repressor and activator of transcription and is specifically involved in the development of pancreatic beta cells, the thyroid, eye, liver and kidney. Mutations in this gene have been associated with neonatal diabetes and congenital hypothyroidism (NDH). Alternatively spliced variants that encode different protein isoforms have been described but the full-length nature of only two have been determined. [provided by RefSeq, Jul 2008]
GLIS3 Gene-Disease associations (from GenCC):
  • neonatal diabetes mellitus with congenital hypothyroidism
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0030592978).
BP6
Variant 9-4118048-G-A is Benign according to our data. Variant chr9-4118048-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 129157.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS2
High Homozygotes in GnomAd4 at 2 AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLIS3NM_001042413.2 linkc.1430C>T p.Ala477Val missense_variant Exon 4 of 11 ENST00000381971.8 NP_001035878.1 Q8NEA6-2Q1PHJ8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLIS3ENST00000381971.8 linkc.1430C>T p.Ala477Val missense_variant Exon 4 of 11 5 NM_001042413.2 ENSP00000371398.3 Q8NEA6-2

Frequencies

GnomAD3 genomes
AF:
0.00193
AC:
293
AN:
152086
Hom.:
2
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00681
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000572
AC:
131
AN:
228988
AF XY:
0.000427
show subpopulations
Gnomad AFR exome
AF:
0.00803
Gnomad AMR exome
AF:
0.000208
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000970
Gnomad OTH exome
AF:
0.000177
GnomAD4 exome
AF:
0.000190
AC:
274
AN:
1438966
Hom.:
1
Cov.:
40
AF XY:
0.000167
AC XY:
119
AN XY:
713242
show subpopulations
African (AFR)
AF:
0.00749
AC:
248
AN:
33112
American (AMR)
AF:
0.000183
AC:
8
AN:
43814
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25008
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39406
South Asian (SAS)
AF:
0.0000119
AC:
1
AN:
83788
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48260
Middle Eastern (MID)
AF:
0.000177
AC:
1
AN:
5664
European-Non Finnish (NFE)
AF:
0.00000273
AC:
3
AN:
1100538
Other (OTH)
AF:
0.000219
AC:
13
AN:
59376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
16
32
49
65
81
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00193
AC:
293
AN:
152204
Hom.:
2
Cov.:
31
AF XY:
0.00179
AC XY:
133
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.00679
AC:
282
AN:
41540
American (AMR)
AF:
0.000392
AC:
6
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
67988
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
12
24
37
49
61
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000576
Hom.:
0
Bravo
AF:
0.00233
ESP6500AA
AF:
0.00660
AC:
29
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000638
AC:
77

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Nov 04, 2013
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 25, 2022
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Dec 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

GLIS3-related disorder Benign:1
Jun 06, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
4.3
DANN
Benign
0.93
DEOGEN2
Benign
0.075
T;.
Eigen
Benign
-0.88
Eigen_PC
Benign
-0.85
FATHMM_MKL
Benign
0.16
N
LIST_S2
Benign
0.62
T;T
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.0031
T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
1.7
L;.
PhyloP100
2.0
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-1.0
N;N
REVEL
Benign
0.047
Sift
Benign
0.11
T;T
Sift4G
Benign
0.34
T;T
Polyphen
0.020
B;B
Vest4
0.14
MVP
0.44
MPC
0.028
ClinPred
0.0053
T
GERP RS
2.7
Varity_R
0.029
gMVP
0.18
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114838275; hg19: chr9-4118048; COSMIC: COSV60923425; COSMIC: COSV60923425; API